Research and Markets: Global Parkinson's Disease Epidemiology and Patient Flow Analysis – 2012

Posted: Published on November 7th, 2012

This post was added by Dr Simmons

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/88l8xd/global) has announced the addition of the "Global Parkinson's Disease Epidemiology and Patient Flow Analysis - 2012" report to their offering.

Fore Pharma announced the results of its Parkinson's Disease patient population study in a new report Global Parkinson's Disease Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Parkinson's Disease epidemiology, Parkinson's Disease diagnosed patients, and Parkinson's Disease treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Parkinson's Disease derived from epidemiological analysis, percentage of patients diagnosed with Parkinson's Disease, and percentage of patients treated with Parkinson's Disease therapy.

The study helps executives estimate Parkinson's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Parkinson's Disease prevalence, Parkinson's Disease diagnosis rate, and Parkinson's Disease treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:

- Parkinson's Disease: Disease Definition

- Parkinson's Disease Patient Flow

- Parkinson's Disease Prevalence

- Parkinson's Disease Diagnosed Patients

Read the original post:
Research and Markets: Global Parkinson's Disease Epidemiology and Patient Flow Analysis - 2012

Related Posts
This entry was posted in Parkinson's Treatment. Bookmark the permalink.

Comments are closed.